Therapy Areas: Cardiovascular
17 June 2019 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) The Janssen Pharmaceutical Companies business has presented new data from PsABio its ongoing, real-world study of ne...
17 June 2019 - Corvidia Therapeutics, a clinical stage biotechnology company, has started patient screening for a Phase 2b dose-finding study of Ziltivekimab, earlier called COR-001, it was reported o...
12 June 2019 - - German pharmaceutical company Boehringer Ingelheim and US-based Eli Lilly and Company (NYSE: LLY) have released full data from the CAROLINA trial demonstrating that Trajenta ...
12 June 2019 - ZOLL Medical Corporation on Tuesday announced a definitive agreement to acquire Cardiac Science Corporation (CSC), a portfolio company of Aurora Resurgence, a Los Angeles-based private ...
12 June 2019 - Cardiovascular company CorMatrix Cardiovascular Inc revealed on Tuesday that it has received US FDA 510(k) market clearance for the Cor PATCH for epicardial tissue support and repair in...
11 June 2019 - - A pre-specified exploratory analysis of renal data from the Phase III DECLARE-TIMI 58 trial, the broadest cardiovascular outcomes trial of a sodium-glucose co-transporter 2 (SGLT...